BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nanosonics Signs Toshiba Medical Systems Corporation as a UK Distributor


4/17/2013 9:21:26 AM

17 April 2013 -- Nanosonics Limited (ASX: NAN) has today announced it has signed an agreement with Toshiba Medical Systems (Toshiba) to be a non-exclusive distributor of trophon® EPR in the United Kingdom.

Chief Executive Officer Dr Ron Weinberger said Toshiba will launch Nanosonics’ first-in-class ultrasound probe disinfection technology in April 2013, coinciding with the new UK fiscal year. Nanosonics will continue to sell directly into the UK market.

“We see trophon EPR as complementary to the Toshiba range of ultrasound machines, and as playing an important role in reducing infection control risk across the healthcare system. Toshiba looks forward to working with Nanosonics in the roll out of this important technology” Mark Hitchman, General Manager of Toshiba Medical Systems, UK, stated.

“We are delighted to be working with Toshiba, a rapidly growing leader in the UK ultrasound market. The health and safety benefits offered by the trophon EPR have attracted strong interest by both sonographers and decontamination professionals throughout the UK. Nanosonics’ direct operations in the UK have seen growth in the demand for product presentation and information from a broad range of healthcare professionals. This strategic engagement with Toshiba will give trophon EPR greater exposure within this market and facilitate adoption of trophon EPR as the Standard of Care in probe decontamination” Dr Weinberger said.

“We estimate that the UK opportunity for trophon EPR is likely to be significant in light of the recent regulatory drivers. It is early days yet and it will take time to build sales volume. However, the signs are encouraging that the UK operations will make an important contribution to global sales revenue” Dr Weinberger commented.

For more information please contact:

Ron Weinberger, CEO or McGregor Grant, CFO, on 02 8063 1600

Kyahn Williamson, Media Relations, Buchan Consulting on (03) 9866 4722



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES